Tsuneya Ikezu, M.D, Ph.D., Professor of Pharmacology and Neurology, received the Inge Grundke-Iqbal Award for Alzheimer\u2019s Research at the Alzheimer\u2019s Association International Conference (AAIC) in Toronto, Ontario, July 24-28, 2016 and is one of two Boston University faculty members to receive a grant from the BrightFocus Foundation. Dr. Ikezu, whose research focuses on molecular therapeutic intervention of neurodegenerative and neuropsychiatric disorders, gave a plenary lecture at the conference.<\/p>\n
The Inge Grundke-Iqbal Award for Alzheimer\u2019s Research recognizes the senior author of the most impactful study on the biology of Alzheimer\u2019s disease and related conditions published during the two calendar years preceding AAIC. The selected paper is \u201cDepletion of microglia and inhibition of exosome synthesis halt tau propagation,\u201d (Nature Neuroscience 2015 Nov;18(11):1584-93)<\/a>.<\/p>\n Dr. Inge Grundke-Iqbal, an internationally renowned neuroscientist, made a milestone discovery in the 1980’s: that abnormal hyperphosphorylation microtubule-associated protein tau is the building block in paired helical filaments (PHFs)\/neurofibrillary tangles (NFTs) in the Alzheimer’s brain. This seminal discovery has contributed greatly to our overall understanding of neurodegeneration and led to major advances in Alzheimer’s research.<\/p>\n